Recent Finacing
Recent Raise
Droplet Biosciences develops post-surgical cancer diagnostics that analyze lymphatic drain fluid—rich in immune cells and biomarkers—to detect residual disease immediately after tumor resection for head and neck cancer.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Droplet Biosciences.
